logo-loader
Oxford Endovascular Ltd

Oxford Endovascular in GLP phase with its brain aneurysm treatment device

Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at the Biotech Showcase in San Francisco.

Oxford Endovascular Limited is a spin out from The University of Oxford. The company is developing metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Fireweed Zinc releases details of drill holes at Tom North...

Fireweed Zinc (CVE: FWZ) CEO Brandon MacDonald sat down with Steve Darling from Proactive Vancouver to discuss their latest result from drilling on the Macmillan Pass Project in the Yukon.  MacDonald telling Proactive the results they found and why they decided to do a step out hole as...

31 minutes ago

2 min read